Key Takeaways of CDDF Webinar : “Transformation of future clinical trials using AI-enhanced imaging biomarkers”
The Cancer Drug Development Forum (CDDF) is pleased to present key takeaways of our live webinar series on “AI and Big Data in Cancer Drug Development.” This series is designed to explore the transformative impact of artificial intelligence and big data on oncology....
ACT EU:Workshop on the Use of External Controls for Evidence Generation in Regulatory Decision-Making
ACT EU is pleased to announce a hybrid workshop on 3 November 2025: “Workshop on the Use of External Controls for Evidence Generation in Regulatory Decision-Making” Registration: Please register via the ACT EU website here: Workshop Registration The Methodology...
NEW PUBLICATION – WHITE PAPER: Overcoming the barriers to treatment of rare cancer patients in the era of precision oncology: A call to action.
The Cancer Drug Development Forum (CDDF) is delighted to announce that the White Paper – “Overcoming the Barriers to Treatment of Rare Cancer”- has been published, following its “Innovation and Access in Rare Cancers” hybrid workshop held on 23-24 September 2024...